Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Looking Into Novartis's Recent Short Interest
February 22, 2024
Tickers
NVS
Tags
Short Ideas
Trading Ideas
Short Sellers
From
Benzinga
Move Over Magnificent 7, Say Hello to the GRANOLAS
February 22, 2024
Tickers
AZN
GLAXF
LRLCY
LVMUY
Tags
SNY
SAP
Market News
From
InvestorPlace
Exit Now! 3 Biotech Stocks to Sell in February 2024
February 21, 2024
Tickers
INCY
MOR
NVS
SAVA
Tags
NASDAQ:NVAS,NASDAQ:SAVA,NASDAQ:INCY,NYSE:NVS,NASDAQ:MOR
Market News
Stocks to Sell
From
InvestorPlace
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
Tickers
AMGN
AZN
BIIB
BMY
Tags
SNY
BIIB
AMGN
From
InvestorPlace
The 3 Biotech Stocks That Could Make Your February Unforgettable
February 15, 2024
Tickers
ACLX
ADCT
AMAM
JNJ
Tags
AMAM
SNY
Market News
From
InvestorPlace
Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says
February 14, 2024
Tickers
BIIB
ESALY
NEWS
NVS
Tags
Trading Ideas
Briefs
News
From
Benzinga
JP Morgan's Bullish View On This Chinese Biotech, Says Pullback Creates Entry Point
February 06, 2024
Tickers
BGNE
NEWS
NVS
Tags
News
General
Briefs
From
Benzinga
Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B
February 06, 2024
Tickers
INCY
MOR
NEWS
NVS
Tags
Biotech
INCY
Benzinga
From
Benzinga
Why Is MorphoSys (MOR) Stock Up 50% Today?
February 05, 2024
Tickers
INCY
MOR
NVS
Tags
INCY
Today's Market
NVS
From
InvestorPlace
MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer
February 05, 2024
Tickers
INCY
MOR
NEWS
NVS
Tags
Market News
MOR
News
From
Benzinga
3 Fabulous Dividend Stocks to Buy in February
February 04, 2024
Tickers
ABBV
NVS
PFE
Tags
Recent Press Releases
NVS
ABBV
From
Motley Fool
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
Tickers
ABBV
AZN
BMY
BNTX
Tags
ABBV
General
PFE
From
Benzinga
Novartis Ag (NVS) Q4 2023 Earnings Call Transcript
January 31, 2024
Tickers
NVS
Tags
Market News
NVS
Recent Press Releases
From
Motley Fool
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 31, 2024
Tickers
AHT
AMD
AMSC
ASH
Tags
SMX
VXRT
GOOGL
From
Benzinga
Why Is European Pharma Giant Novartis Stock Trading Lower Today?
January 31, 2024
Tickers
NEWS
NVS
Tags
Market News
Movers
Health Care
From
Benzinga
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
January 31, 2024
Tickers
AMD
BA
BSX
CHRW
Tags
premarket story
News
NDAQ
From
Benzinga
Alphabet Reports Q4 Results, Joins AMD, Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 31, 2024
Tickers
AMD
AMSC
BITF
BTDR
Tags
News
AMSC
GOOG
From
Benzinga
Earnings Scheduled For January 31, 2024
January 31, 2024
Tickers
ADP
AFL
ALGN
APTV
Tags
UGI
CLB
NXT
From
Benzinga
3 Hidden Healthcare Stocks Poised for a Breakout This Year
January 30, 2024
Tickers
MCK
NVS
Tags
TDOC/NYSE
Market News
Stocks to Buy
From
InvestorPlace
Earnings Outlook For Novartis
January 30, 2024
Tickers
NVS
Tags
Earnings
Market News
NVS
From
Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
Tickers
AAPL
ABBV
AMD
AMZN
Tags
ROK
SNY
Magnificent Seven
From
Benzinga
Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of "Risks Of Secondary Cancer'
January 24, 2024
Tickers
BMY
GILD
JNJ
NEWS
Tags
Briefs
BMY
News
From
Benzinga
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
Tickers
AZN
BMY
GILD
GRCL
Tags
AZN
GRCL
Briefs
From
Benzinga
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
January 12, 2024
Tickers
AZN
BMY
CYTK
NEWS
Tags
BMY
General
News
From
Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
January 11, 2024
Tickers
CYTK
NEWS
NVS
Tags
General
News
Briefs
From
Benzinga
What's Been Happening With Cytokinetics Stock?
January 09, 2024
Tickers
CYTK
NEWS
NVS
Tags
CYTK
Movers
Market News
From
Benzinga
Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?
January 08, 2024
Tickers
CYTK
NEWS
NVS
Tags
NVS
why it's moving
Benzinga
From
Benzinga
Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?
January 08, 2024
Tickers
EXEL
MRK
NEWS
NVS
Tags
Briefs
Markets
MRK
From
Benzinga
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery
January 08, 2024
Tickers
GOOG
GOOGL
LLY
NEWS
Tags
LLY
NVS
GOOGL
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
January 05, 2024
Tickers
NVS
Tags
Short Sellers
Benzinga
NVS
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.